SEER, INC. Selling, General and Administrative Expense
SEER, INC. (SEER) reported Selling, General and Administrative Expense of $10.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-11
- SEER, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $10.14M, a 4.86% decline year-over-year.
- SEER, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $9.43M, a 17.57% decline year-over-year.
- SEER, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $9.83M, a 23.79% decline year-over-year.
- SEER, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $10.66M, a 19.83% decline year-over-year.
- SEER, INC. selling, general and administrative expense for fiscal 2025 was $42.58M, a 24.73% decline from fiscal 2024.
- SEER, INC. selling, general and administrative expense for fiscal 2024 was $56.57M, a 4.04% decline from fiscal 2023.
- SEER, INC. selling, general and administrative expense for fiscal 2023 was $58.95M, a 0.72% increase from fiscal 2022.
- SEER, INC. selling, general and administrative expense for fiscal 2022 was $58.53M, a 27.90% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.14M 10-Q · filed 2026-08-11 | $19.57M 10-Q · filed 2026-08-11 | $29.40M derived: sum of 3 quarters · filed 2026-08-11 | $40.05M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $9.43M 10-Q · filed 2026-05-13 | $19.26M derived: sum of 2 quarters · filed 2026-05-13 | $29.92M derived: sum of 3 quarters · filed 2026-05-13 | $40.57M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $9.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $20.48M derived: sum of 2 quarters · filed 2026-03-02 | $31.14M derived: sum of 3 quarters · filed 2026-08-11 | $42.58M 10-K · filed 2026-03-02 |
| 2025-09-30 | $10.66M 10-Q · filed 2025-11-06 | $21.32M derived: sum of 2 quarters · filed 2026-08-11 | $32.76M 10-Q · filed 2025-11-06 | $45.65M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $10.66M 10-Q · filed 2026-08-11 | $22.10M 10-Q · filed 2026-08-11 | $34.99M derived: sum of 3 quarters · filed 2026-08-11 | $48.29M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $11.44M 10-Q · filed 2026-05-13 | $24.34M derived: sum of 2 quarters · filed 2026-05-13 | $37.63M derived: sum of 3 quarters · filed 2026-05-13 | $53.73M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $12.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $26.19M derived: sum of 2 quarters · filed 2026-03-02 | $42.28M derived: sum of 3 quarters · filed 2026-03-02 | $56.57M 10-K · filed 2026-03-02 |
| 2024-09-30 | $13.30M 10-Q · filed 2025-11-06 | $29.39M derived: sum of 2 quarters · filed 2025-11-06 | $43.68M 10-Q · filed 2025-11-06 | $56.74M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $16.09M 10-Q · filed 2025-08-06 | $30.38M 10-Q · filed 2025-08-06 | $43.45M derived: sum of 3 quarters · filed 2025-08-06 | $58.22M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $14.29M 10-Q · filed 2025-05-13 | $27.36M derived: sum of 2 quarters · filed 2025-05-13 | $42.13M derived: sum of 3 quarters · filed 2025-05-13 | $58.20M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $13.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $27.84M derived: sum of 2 quarters · filed 2025-03-03 | $43.91M derived: sum of 3 quarters · filed 2025-03-03 | $58.95M 10-K · filed 2025-03-03 |
| 2023-09-30 | $14.77M 10-Q · filed 2024-11-06 | $30.84M derived: sum of 2 quarters · filed 2024-11-06 | $45.88M 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $16.07M 10-Q · filed 2024-08-08 | $31.11M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $15.04M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $58.53M 10-K · filed 2024-03-04 | |||
| 2021-12-31 | $45.76M 10-K · filed 2023-03-06 | |||
| 2020-12-31 | $15.36M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |